Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.04 USD 0.01%
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
Accounts Payable Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Accounts Payable
€99.5m
CAGR 3-Years
31%
CAGR 5-Years
36%
CAGR 10-Years
40%
Genmab A/S
CSE:GMAB
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Accounts Payable
kr229.7m
CAGR 3-Years
61%
CAGR 5-Years
50%
CAGR 10-Years
38%
B
Bavarian Nordic A/S
CSE:BAVA
Accounts Payable
kr1.1B
CAGR 3-Years
56%
CAGR 5-Years
59%
CAGR 10-Years
29%
F
Fluoguide AS
STO:FLUO
Accounts Payable
kr4.1m
CAGR 3-Years
15%
CAGR 5-Years
214%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Accounts Payable
kr5.5m
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
13%

See Also

What is Ascendis Pharma A/S's Accounts Payable?
Accounts Payable
99.5m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Accounts Payable amounts to 99.5m EUR.

What is Ascendis Pharma A/S's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
40%

Over the last year, the Accounts Payable growth was -18%. The average annual Accounts Payable growth rates for Ascendis Pharma A/S have been 31% over the past three years , 36% over the past five years , and 40% over the past ten years .

Back to Top